Apoptosis, graft rejection, and transplantation tolerance

Transplantation

Volumn 65, Issue 7, 1998, Pages 869-875

  Kabelitz, Dieter ^a  

^a PAUL EHRLICH INSTITUT   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS; GRAFT REJECTION; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOSUPPRESSIVE TREATMENT; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE;

EID: 0032522514     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199804150-00003     Document Type: Review

References (75)

1. Kisielow P, von Boehmer H. Development and selection of T cells: facts and puzzles. Adv Immunol 1995; 58: 87.
2. Cohen JJ, Duke RC, Fadok VA, Sellins KS. Apoptosis and programmed cell death in immunity. Annu Rev Immunol 1992; 10: 267.
3. Gorczyca W, Gong J, Darzynkiewicz Z. Detection of DNA strand breaks in individual apoptotic cells by in situ terminal deoxynucleotidyl transferase and nick translation assays. Cancer Res 1993; 53: 1945.
4. Kabelitz D, Pohl T, Pechhold K. Activation-induced cell death (apoptosis) of mature peripheral T lymphocytes. Immunol Today 1993; 14: 338.
5. Arnold B, Schönrich G, Hämmerling GJ. Multiple levels of peripheral tolerance. Immunol Today 1993; 14: 12.
6. Kabelitz D, Janssen O. Antigen-induced death of T-lymphocytes. Front Biosci 1997; 2: 61.
7. Braun MY, McCormack A, Webb G, Batchelor JR. Evidence for clonal anergy as a mechanism responsible for the maintenance of transplantation tolerance. Eur J Immunol 1993; 23: 1462.
8. Mueller DL, Jenkins MK, Schwartz RH. Clonal expansion versus functional clonal inactivation: a costimulatory signalling pathway determines the outcome of T cell antigen receptor occupancy. Annu Rev Immunol 1989; 7: 445.
9. Lenschow DJ, Zeng Y, Hathcock KS, et al. Inhibition of transplant rejection following treatment with anti-B7-2 and anti-B7-1 antibodies. Transplantation 1995; 60: 1171.
10. Guérette B, Gingras M, Wood K, Roy R, Tremblay JP. Immuno-suppression with monoclonal antibodies and CTLA4-Ig after myoblast transplantation in mice. Transplantation 1996; 62: 962.
11. Larsen CP, Elwood ET, Alexander DZ, et al. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature 1996; 381: 434.
12. Woodward JE, Qin L, Chavin KD, et al. Blockade of multiple costimulatory receptors induces hyporesponsiveness: inhibition of CD2 plus CD28 pathways. Transplantation 1996; 62: 1011.
13. Azuma H, Chandraker A, Nadeau K, et al. Blockade of T-cell costimulation prevents development of experimental chronic renal allograft rejection. Proc Natl Acad Sci USA 1996; 93: 12439.
14. Sayegh MH, Akalin E, Hancock WW, et al. CD28-B7 blockade after alloantigenic challenge in vivo inhibits Th1 cytokines but spares Th2. J Exp Med 1995; 181: 1869.
15. Ferraresso M, Tian L, Ghobrial R, Stepkowski SM, Kahan BD. Rapamycin inhibits production of cytotoxic but not noncytotoxic antibodies and preferentially activates T helper 2 cells that mediate long-term survival of heart allografts in rats. J Immunol 1994; 153: 3307.
16. Takeuchi T, Lowry RP, Konieczny B. Heart allografts in murine systems: the differential activation of Th2-like effector cells in peripheral tolerance. Transplantation 1992; 53: 1281.
17. Wesselborg S, Janssen O, Kabelitz D. Induction of activation-driven death (apoptosis) in activated but not resting peripheral blood T cells. J Immunol 1993; 150: 4338.
18. Klas C, Debatin KM, Jonker RR, Krammer PH. Activation interferes with the APO-1 pathway in mature human T cells. Int Immunol 1993; 5: 625.
19. Alderson MR, Tough TW, Davis-Smith T, et al. Fas ligand mediates activation-induced cell death in human T lymphocytes. J Exp Med 1995; 181: 71.
20. Dhein J, Walczak H, Bäumler C, Debatin K-M, Krammer PH. Autocrine T cell suicide mediated by Apo1/(Fas/CD95). Nature 1995; 373: 438.
21. Van Parijs L, Abbas AK. Role of Fas-mediated cell death on the regulation of immune responses. Curr Opin Immunol 1996; 8: 355.
22. Nagata S. Apoptosis by death factor. Cell 1997; 88: 355.
23. Zheng L, Fisher G, Miller RE, Peschon J, Lynch DH, Lenardo MJ. Induction of apoptosis in mature T cells by tumour necrosis factor. Nature 1995; 377: 348.
24. Chinnayan AM, O'Rourke K, Yu G-L, et al. Signal transduction by DR-3, a death domain-containing receptor related to TNFR-1 and CD95. Science 1996; 274: 990.
25. Bodmer J-L, Burns K, Schneider P, et al. TRAMP, a novel apoptosis-mediating receptor with sequence homology to tumor necrosis factor receptor 1 and Fas (Apo-1/CD95). Immunity 1997; 6: 79.
26. Pan G, O'Rourke K, Chinnaiyan AM, et al. The receptor for the cytotoxic ligand TRAIL. Science 1997; 276: 111.
27. Wiley SR, Schooley K, Smolak PJ, et al. Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 1995; 3: 673.
28. Pitti RM, Marsters SA, Ruppert S, Donahue CJ, Moore A, Ashkenazi A. Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family. J Biol Chem 1996; 271: 12687.
29. Peter ME, Dhein J, Ehret A, et al. APO-1(CD95)-dependent and -independent antigen receptor-induced apoptosis in human T and B cell lines. Int Immunol 1995; 7: 1873.
30. Katsikis PD, García-Ojeda ME, Wunderlich ES, et al. Activation-induced peripheral blood T cell apoptosis is Fas independent in HIV-infected individuals. Int Immunol 1996; 8: 1311.
31. Peter ME, Kischkel FC, Scheuerpflug CG, Medema JP, Debatin K-M, Krammer PH. Resistance of cultured peripheral T cells towards activation-induced cell death involves a lack of recruitment of FLICE (MACH/caspase 8) to the CD95 death-inducing signaling complex. Eur J Immunol 1997; 27: 1207.
32. Radvanyi LG, Shi Y, Vaziri H, et al. CD28 costimulation inhibits TCR-induced apoptosis during a primary T cell response. J Immunol 1996; 156: 1788.
33. Newell MK, Haughn LJ, Maroun CR, Julius MH. Death of mature T cells by separate ligation of CD4 and the T-cell receptor for antigen. Nature 1990; 347: 286.
34. Oberg HH, Sanzenbacher R, Lengl-Janßen B, et al. Ligation of cell surface CD4 inhibits activation-induced death of human T lymphocytes at the level of Fas-ligand expression. J Immunol 1997; 159: 5742.
35. Lenardo MJ. Interleukin-2 programs mouse αβ T lymphocytes for apoptosis. Nature 1991; 353: 858.
36. Boehme SA, Lenardo MJ. Propriocidal apoptosis of mature T lymphocytes occurs at S phase of the cell cycle. Eur J Immunol 1993; 23: 1552.
37. Sambhara SR, Miller RG. Programmed cell death of T cells signaled by the T cell receptor and the α3 domain of class I MHC. Science 1991; 252: 1424.
38. Pohl T, Pechhold K, Oberg H-H, Wilbert OM, Kabelitz D. Antigen-induced death of alloreactive human T-lymphocytes occurs in the absence of low molecular weight DNA fragmentation. Cell Immunol 1995; 166: 187.
39. Zhang L. The fate of adoptively transferred antigen-specific T cells in vivo. Eur J Immunol 1996; 26: 2208.
40. Zavazava N, Krönke M. Soluble HLA class I molecules induce apoptosis in alloreactive cytotoxic T lymphocytes. Nature Med 1996; 2: 1005.
41. + T lymphocytes. J Immunol 1993; 151: 2368.
42. Kabelitz D, Oberg H-H, Pohl T, Pechhold K. Antigen-induced death of mature T lymphocytes: analysis by flow cytometry. Immunol Rev 1994; 142: 157.
43. Alexander-Miller MA, Leggatt GR, Sarin A, Berzofsky JA. Role of antigen, CD8, and cytotoxic T lymphocyte (CTL) avidity in high dose antigen induction of apoptosis of effector CTL. J Exp Med 1996; 184: 485.
44. Critchfield JM, Racke MK, Zúñiga-Pflücker JC, et al. T cell deletion in high antigen dose therapy of autoimmune encephalomyelitis. Science 1994; 263: 1139.
45. Liblau RS, Pearson CI, Shokat K, Tisch R, Yang YD, McDevitt HO. High-dose soluble antigen: peripheral T-cell proliferation or apoptosis. Immunol Rev 1994; 142: 193.
46. Kabelitz D, Pohl T, Pechhold K. T cell apoptosis triggered via the CD3/T cell receptor complex and alternative activation pathways. Curr Top Microbiol Immunol 1995; 200: 1.
47. Wang J, Nonomura N, Ichimaru N, et al. Expression of Fas and Fas ligand in renal grafts with acute and chronic rejection in the rat model. J Interferon Cytokine Res 1997; 17: 369.
48. Kato S, Akasaka Y, Kawamura S. Fas antigen expression and its relationship with apoptosis in transplanted kidney. Pathol Int 1997; 47: 230.
49. Ito H, Kasagi N, Shomori K, Osaki M, Adachi H. Apoptosis in the human allografted kidney: analysis by terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labeling. Transplantation 1995; 60: 794.
50. Laine J, Etelaemaeki P, Holmberg C, Dunkel L. Apoptotic cell death in human chronic renal allograft rejection. Transplantation 1997; 63: 101.
51. Sharma VK, Bologa RM, Li B, et al. Molecular executors of cell death: differential intrarenal expression of Fas ligand, Fas, granzyme B, and perform during acute and/or chronic rejection of human renal allograft. Transplantation 1996; 62: 1860.
52. Krams SM, Egawa H, Quinn MB, Villanueva JC, Garcia-Kennedy R, Martinez OM. Apoptosis as a mechanism of cell death in liver allograft rejection. Transplantation 1995; 59: 621.
53. Afford SC, Hubscher S, Strain AJ, Adams DH, Neuberger JM. Apoptosis in the human liver during allograft rejection and end-stage liver disease. J Pathol 1995; 176: 373.
54. Nawaz S, Fennell RH. Apoptosis of bile duct epithelial cells in hepatic allograft rejection. Histopathology 1994; 25: 137.
55. Fayyazi A, Schlemminger R, Gieseler R, Peters JH, Radzun HJ. Apoptosis in the small intestinal allograft of the rat. Transplantation 1997; 63: 947.
56. Szabolcs M, Michler RE, Yang X, et al. Apoptosis of cardiac myocytes during cardiac allograft rejection: relation to induction of nitric oxide synthase. Circulation 1996; 94: 1665.
57. Laguens RP, Meckert PM, Martino JS, Perrone S, Favaloro R. Identification of programmed cell death (apoptosis) in situ by means of specific labeling of nuclear DNA fragments in heart biopsy samples during acute rejection episodes. J Heart Lung Transplant 1996; 15: 911.
58. White WL, Zhang YL, Shelby J, et al. Myocardial apoptosis in a heterotopic murine heart transplantation model of chronic rejection and graft vasculopathy. J Heart Lung Transplant 1997; 16: 250.
59. Bergese SD, Klenotic SM, Wakely ME, Sedmak DD, Orosz CG. Apoptosis in murine cardiac grafts. Transplantation 1997; 63: 320.
60. Larsen CP, Alexander DZ, Hendrix R, Ritchie SC, Pearson TC. Fas-mediated cytotoxicity: an immunoeffector or immunoregulatory pathway in T cell-mediated immune responses? Transplantation 1995; 60: 221.
61. Jollow KC, Sundstrom JB, Gravanis MB, Kanter K, Herskowitz A, Ansari AA. Apoptosis of mononuclear cell infiltrates in cardiac allograft biopsy specimens questions studies of biopsy-cultured cells. Transplantation 1997; 63: 1482.
62. Savill J, Dransfield I, Nogg N, Haslett C. Vitronectin receptor-mediated phagocytosis of cells undergoing apoptosis. Nature 1990; 343: 170.
63. Bellgrau D, Gold D, Selawry H, Moore J, Franzusoff A, Duke RC. A role for CD95 ligand in preventing graft rejection. Nature 1995; 377: 630.
64. Stuart PM, Griffith TS, Usui N, Pepose J, Yu X, Ferguson TA. CD95 ligand (FasL)-induced apoptosis is necessary for corneal allograft survival. J Clin Invest 1997; 99: 396.
65. Larkin DFP, Alexander RA, Cree IA. Infiltrating inflammatory cell phenotypes and apoptosis in rejected human corneal allografts. Eye 1997; 11: 68.
66. Meehan SM, McCluskey RT, Pascual M, et al. Cytotoxicity and apoptosis in human renal allografts: identification, distribution, and quantitation of cells with a cytotoxic granule protein GMP-17 (TIA-1) and cells with fragmented nuclear DNA. Lab Invest 1997; 76: 639.
67. Qian S, Lu L, Fu F, et al. Apoptosis within spontaneously accepted mouse liver allografts: evidence for deletion of cytotoxic T cells and implications for tolerance induction. J Immunol 1997; 158: 4654.
68. Lau HT, Yu M, Fontana A, Stoeckert CJ Jr. Prevention of islet allograft rejection with engineered myoblasts expressing FasL in mice. Science 1996; 273: 109.
69. Korbutt GS, Elliott JF, Rajotte RV. Cotransplantation of allogeneic islets with allogeneic testicular cell aggregates allows long-term graft survival without systemic immunosuppression. Diabetes 1997; 46: 317.
70. Kang SM, Schneider DB, Lin Z, et al. Fas ligand expression in islets of Langerhans does not confer immune privilege and instead targets them for rapid destruction. Nature Med 1997; 3: 738.
71. Allison J, Georgiou HM, Strasser A, Vaux DL. Transgenic expression of CD95 ligand on islet beta cells induces a granulocytic infiltration but does not confer immune privilege upon islet allografts. Proc Natl Acad Sci USA 1997; 94: 3943.
72. Jones ND, Fluck NC, Roelen DL, Mellor AL, Morris PJ, Wood KJ. Deletion of alloantigen-reactive thymocytes as a mechanism of adult tolerance induction following intrathymic antigen administration. Eur J Immunol 1997; 27: 1591.
73. Janssen O, Wesselborg S, Kabelitz D. Immunosuppression by OKT3: induction of programmed cell death (apoptosis) as a possible mechanism of action. Transplantation 1992; 53: 233.
74. Bonnefoy-Berard N, Revillard J-P. Mechanisms of immunosuppression induced by antithymocyte globulins and OKT3. J Heart Lung Transplant 1996; 15: 435.
75. Migita K, Eguchi K, Kawabe Y, Tsukada T, Mizokami A, Nagataki S. FK506 augments activation-induced programmed cell death of T lymphocytes in vivo. J Clin Invest 1995; 96: 727.